Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-059940
Filing Date
2021-10-07
Accepted
2021-10-07 16:44:08
Documents
1
Period of Report
2021-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4124
  Complete submission text file 0001209191-21-059940.txt   5517
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036
Business Address
Fitzgerald Kevin Joseph (Reporting) CIK: 0001886431 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 211312816